Effects of genetic background on tumorigenesis in p53‐deficient mice
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Mice with disrupted germline p53 alleles have been engineered by us and others and have been shown to have enhanced susceptibility to spontaneous tumors of various types. We monitored a large number of p53‐deficient mice(p53+/− and p53−/−) and their wild‐type littermates(p53+/+) of two different genetic backgrounds(129/5v and mixed C57BL/6 × 129/5v) up to 2 yr of age.p53+/− and p53−/− 129/Sv mice show accelerated tumorigenesis rates compared with their p53‐deficient counterparts of mixed C57BL/6 × 129/Sv genetic background. The tumor spectra of the two strains of mice are similar except that almost half of 129/Sv p53−/− males develop malignant teratomas, whereas these tumors are rarely observed in C57BL/6 × 129/Sv mice and never in 129/Sv p53+/− males. In the study reported here, we further characterized the lymphomas that arose in the p53‐nullizygous mice and found that over three‐quarters of the lymphomas were of thymic origin and contained primarily immature(CD4+/CD8+) T‐cells, whereas the remainder originated in the spleen and peripheral lymph nodes and were of B‐cell type. The high incidence of early‐onset lymphomas in the nullizygous mice makes these animals a good lymphoma model, whereas the heterozygous mice may be a useful model for Li‐Fraumeni syndrome, a human inherited cancer predisposition.© 1995 Wiley‐Liss, Inc
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Extensive aCGH studies on human cancers using a variety of platforms have revealed widespread focal amplifications and deletions in human cancers which are now known to harbor oncogenes and tumor suppressor genes, respectively (113).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [113]
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citationGerm Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
Self-citationKemp, C. J., Donehower, L. A., Bradley, A., & Balmain, A. (1993) · Cell · doi:10.1016/0092-8674(93)90461-x · Cited by 457
Self-citationLavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
Spontaneous Testicular Teratomas in an Inbred Strain of Mice
Stevens, L. C., & Little, C. C. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.11.1080 · Cited by 379
Research works printed but not linked: 1
- Stevens LC, 1979, Inbred and Genetically Defined Strains of Laboratory Animals: Mouse and Rat, 207
Cited by
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Pluripotency of spermatogonial stem cells from adult mouse testis
Guan, K., Nayernia, K., Maier, L. S., Wagner, S., Dressel, R., Lee, J. H., Nolte, J., Wolf, F., Li, M., Engel, W., et al. (2006) · Nature · doi:10.1038/nature04697 · Cited by 899
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues, P., Schäuble, B., Hausen, A. Z., Estève, J., & Ohgaki, H. (1997) · Europe PMC (PubMed Central) · Cited by 488
Foundations in Cancer Research p53 and ATM: Cell Cycle, Cell Death, and Cancer
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60095-0 · Cited by 300
Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis
Müller, U. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00021-0 · Cited by 266
Sarcomas in TP53 germline mutation carriers: A review of the IARC TP53 database
Ognjanovic, S., Olivier, M., Bergemann, T. L., & Hainaut, P. (2012) · Cancer · doi:10.1002/cncr.26390 · Cited by 238
Germline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
Hwang, S.-J., Lozano, G., Amos, C. I., & Strong, L. C. (2003) · The American Journal of Human Genetics · doi:10.1086/374567 · Cited by 229
Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., & Leder, P. (1997) · Nature Genetics · doi:10.1038/ng0897-397 · Cited by 226
The role of p53 in tumour suppression: lessons from mouse models
Attardi, L. D., & Jacks, T. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050269 · Cited by 201
Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function.
Lydon, J. P., Ge, G., Kittrell, F. S., Medina, D., & O’Malley, B. W. (1999) · PubMed · Cited by 190
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
Bristow, R. G., Benchimol, S., & Hill, R. P. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01806-3 · Cited by 192
Arsenic induces apoptosis through a c-Jun NH2-terminal kinase-dependent, p53-independent pathway.
Huang, C., Ma, W. Y., Li, J., & Dong, Z. (1999) · PubMed · Cited by 197
Reduced Mcm2 Expression Results in Severe Stem/Progenitor Cell Deficiency and Cancer
Pruitt, S. C., Bailey, K. J., & Freeland, A. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0483 · Cited by 172
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
Pierce, A. M., Gimenez-Conti, I. B., Schneider-Broussard, R., Martinez, L. A., Conti, C. J., & Johnson, D. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8858 · Cited by 156
Deletion of Ku70, Ku80, or Both Causes Early Aging without Substantially Increased Cancer
Li, H., Vogel, H., Holcomb, V. B., Gu, Y., & Hasty, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00785-07 · Cited by 150
Self-citationα-Galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis
Hayakawa, Y., Rovero, S., Forni, G., & Smyth, M. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630663100 · Cited by 150
Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
Komarova, E. A., Antoch, M. P., Novototskaya, L. R., Chernova, O. B., Paszkiewicz, G., Leontieva, O. V., Blagosklonny, M. V., & Gudkov, A. V. (2012) · Aging · doi:10.18632/aging.100498 · Cited by 146
Pathology of Aging B6;129 Mice
Haines, D. C., Chattopadhyay, S., & Ward, J. M. (2001) · Toxicologic Pathology · doi:10.1080/019262301753385988 · Cited by 140
Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis
Iozzo, R. V., Chakrani, F., Perrotti, D., McQuillan, D. J., Skórski, T., Calabretta, B., & Eichstetter, I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3092 · Cited by 142
Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive
Coschi, C. H., Martens, A. L., Ritchie, K., Francis, S. M., Chakrabarti, S., Berube, N. G., & Dick, F. A. (2010) · Genes & Development · doi:10.1101/gad.1917610 · Cited by 128
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
“B-cell tumors have been observed in p53 / mice (Donehower et al, 1995; Ward et al, 1999); however, fatal thymic lymphoblastic T-cell lymphomas and sarcomas may have limited the development and progression of B-cell tumors in p53 / animals.”
BackgroundRegulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122
Su, T., Suzui, M., Wang, L., Lin, C.-S., Xing, W.-Q., & Weinstein, I. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332160100 · Cited by 123
Wolfer, D. P., Müller, U., Stagljar, M., & Lipp, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00673-2 · Cited by 129
Szabova, L., Yin, C., Bupp, S., Guerin, T. M., Schlomer, J. J., Householder, D. B., Baran, M. L., Yi, M., Song, Y., Sun, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3834 · Cited by 122
Tong, W.-M., Hande, M. P., Lansdorp, P. M., & Wang, Z.-Q. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4046-4054.2001 · Cited by 121
Viewpoint: Are Studies in Genetically Altered Mice Out of Control?
Sigmund, C. D. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1425 · Cited by 119
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Swann, J. B., Uldrich, A. P., van Dommelen, S., Sharkey, J., Murray, W. K., Godfrey, D. I., & Smyth, M. J. (2009) · Blood · doi:10.1182/blood-2009-01-198564 · Cited by 116
Regulated Genomic Instability and Neoplasia in the Lymphoid Lineage
Vanasse, G. J., Concannon, P., & Willerford, D. M. (1999) · Blood · doi:10.1182/blood.v94.12.3997 · Cited by 116
Loss of p53 Promotes Anaplasia and Local Invasion in ret/PTC1-Induced Thyroid Carcinomas
Perle, K. M. D. L., Jhiang, S. M., & Capen, C. C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64577-4 · Cited by 112
p53 +/- Hemizygous Knockout Mouse: Overview of Available Data
Storer, R. D., French, J. E., Haseman, J., Hajian, G., LeGrand, E. K., Long, G. G., Mixson, L. A., Ochoa, R., Sagartz, J. E., & Soper, K. A. (2001) · Toxicologic Pathology · doi:10.1080/019262301753178465 · Cited by 104
Autophagy promotes mammalian survival by suppressing oxidative stress and p53
Yang, Y., Karsli-Uzunbas, G., Poillet-Perez, L., Sawant, A., Hu, Z. S., Zhao, Y., Moore, D., Hu, W., & White, E. (2020) · Genes & Development · doi:10.1101/gad.335570.119 · Cited by 100
“1C,D; Donehower et al. 1995).”
BackgroundInactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice
Wikonkál, N. M., Remenyik, É., Knezevic, D., Zhang, W., Liu, M., Zhao, H., Berton, T. R., Johnson, D. G., & Brash, D. E. (2003) · Nature Cell Biology · doi:10.1038/ncb1001 · Cited by 101
The relationship between aging and carcinogenesis: a critical appraisal
Anisimov, V. N. (2003) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00121-x · Cited by 111
Dubé, N., Bourdeau, A., Heinonen, K. M., Cheng, A., Lee Loy, A., & Tremblay, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1353 · Cited by 94
High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase
Iwakuma, T., Sakumi, K., Nakatsuru, Y., Kawate, H., Igarashi, H., Shiraishi, A., Tsuzuki, T., Ishikawa, T., & Sekiguchi, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.8.1631 · Cited by 100
Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase
Vanasse, G. J., Halbrook, J., Thomas, S., Burgess, A., Hoekstra, M. F., Disteche, C. M., & Willerford, D. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6658 · Cited by 91
Synapsin I Cre transgene expression in male mice produces germline recombination in progeny
Rempe, D., Vangeison, G., Hamilton, J., Li, Y., Jepson, M., & Federoff, H. J. (2006) · genesis · doi:10.1002/gene.20183 · Cited by 88
53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis
Morales, J. C., Franco, S., Murphy, M. M., Bassing, C. H., Mills, K. D., Adams, M. M., Walsh, N. C., Manis, J. P., Rassidakis, G. Z., Alt, F. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511259103 · Cited by 88
Loizou, E., Banito, A., Livshits, G., Ho, Y.-J., Koche, R. P., Sánchez-Rivera, F. J., Mayle, A., Chen, C.-C., Kinalis, S., Bagger, F. O., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1391 · Cited by 88
“As commonly observed in Trp53−/− mice (23), most animals develop thymic lymphoma, although some had leukemias and, rarely, a mixed disease (leukemia and lymphoma; Fig.”
BackgroundUeda, E., Kurebayashi, S., Sakaue, M., Backlund, M., Koller, B. H., & Jetten, A. M. (2002) · PubMed · Cited by 87
Evaluating Mutant Mice: Anatomic Pathology
Brayton, C. F., Justice, M. J., & Montgomery, C. A. (2001) · Veterinary Pathology · doi:10.1354/vp.38-1-1 · Cited by 85
Self-citationVenkatachalam, S., Tyner, S. D., Pickering, C. R., Boley, S., Recio, L., French, J. E., & Donehower, L. A. (2001) · Toxicologic Pathology · doi:10.1080/019262301753178555 · Cited by 83
Self-citationLu, D., He, A., Tan, M., Mrad, M., Daibani, A. E., Hu, D., Liu, X., Kleiboeker, B. A., Che, T., Hsu, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48471-2 · Cited by 99
Detection of functional single-nucleotide polymorphisms that affect apoptosis
Harris, S. L., Gil, G. A., Robins, H. S., Hu, W., Hirshfield, K. M., Bond, E. E., Bond, G. L., & Levine, A. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508390102 · Cited by 87
Dunnick, J. K., Hardisty, J. F., Herbert, R. A., Seely, J. C., Furedi, E. M., Foley, J. F., Lacks, G. D., Stasiewicz, S., & French, J. E. (1997) · Toxicologic Pathology · doi:10.1177/019262339702500601 · Cited by 80
The evolution of thymic lymphomas in p53 knockout mice
Dudgeon, C., Chan, C., Kang, W., Sun, Y., Emerson, R., Robins, H., & Levine, A. J. (2014) · Genes & Development · doi:10.1101/gad.252148.114 · Cited by 77
Tying the loose ends together in DNA double strand break repair with 53BP1.
Adams, M. M., & Carpenter, P. B. (2006) · Cell Division · doi:10.1186/1747-1028-1-19 · Cited by 91
Cell and tissue responses to genotoxic stress
Coates, P. J., Lorimore, S. A., & Wright, E. G. (2005) · The Journal of Pathology · doi:10.1002/path.1701 · Cited by 85
Galluzzi, L., Morselli, E., Kepp, O., Vitale, I., Pinti, M., & Kroemer, G. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3504 · Cited by 74
Genetic background determines mouse strain differences in inflammatory angiogenesis
Marques, S. M., Campos, P. P., Castro, P. R., Cardoso, C. C., Ferreira, M. A. N. D., & Andrade, S. P. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.08.011 · Cited by 85
Gulezian, D., Jacobson‐Kram, D., McCullough, C., Olson, H. M., Recio, L., Robinson, D. E., Storer, R. D., Tennant, R. W., Ward, J. M., & Neumann, D. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800320 · Cited by 74
The Transcriptional Landscape of p53 Signalling Pathway
Tanikawa, C., Zhang, Y., Yamamoto, R., Tsuda, Y., Tanaka, M., Funauchi, Y., Mori, J., Imoto, S., Yamaguchi, R., Nakamura, Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.05.017 · Cited by 77
DNA Damage, Somatic Aneuploidy, and Malignant Sarcoma Susceptibility in Muscular Dystrophies
Schmidt, W. M., Uddin, M. H., Dysek, S., Moser-Thier, K., Pirker, C., Höger, H., Ambros, I. M., Ambros, P. F., Berger, W., & Bittner, R. E. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002042 · Cited by 81
Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma
Haney, S. L., Upchurch, G. M., Opavska, J., Klinkebiel, D. L., Hlady, R. A., Roy, S., Dutta, S., Datta, K., & Opavský, R. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006334 · Cited by 70
Kelly, P. N., White, M. J., Goschnick, M. W., Fairfax, K. A., Tarlinton, D. M., Kinkel, S. A., Bouillet, P., Adams, J. M., Kile, B. T., & Strasser, A. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.43 · Cited by 68
The role of p63 in germ cell apoptosis in the developing testis
Petre‐Lazar, B., Livera, G., Moreno, S. G., Trautmann, E., Duquenne, C., Hanoux, V., Habert, R., & Coffigny, H. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20829 · Cited by 66
Loss of DNA Polymerase ζ Enhances Spontaneous Tumorigenesis
Wittschieben, J. P., Patil, V., Glushets, V., Robinson, L. J., Kusewitt, D. F., & Wood, R. D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4267 · Cited by 66
Yamamoto, M., Tsukamoto, T., Sakai, H., Shirai, N., Ohgaki, H., Furihata, C., Donehower, L. A., Yoshida, K., & Tatematsu, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.10.1891 · Cited by 74
Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null mice.
Zindy, F., Nilsson, L. M., Nguyen, L., Meunier, C., Smeyne, R. J., Rehg, J. E., Eberhart, C. G., Sherr, C. J., & Roussel, M. F. (2003) · PubMed · Cited by 78
Coates, P. J., Lorimore, S. A., Lindsay, K. J., & Wright, E. G. (2003) · The Journal of Pathology · doi:10.1002/path.1456 · Cited by 69
The Nature of the Heterozygous Trp53 Knockout Model for Identifi cation of Mutagenic Carcinogens
French, J. E., Storer, R. D., & Donehower, L. A. (2001) · Toxicologic Pathology · doi:10.1080/019262301753178456 · Cited by 65
Self-citationCrippling p53 activities via knock-in mutations in mouse models
Iwakuma, T., & Lozano, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210278 · Cited by 83
Rescue of Xrcc1 knockout mouse embryo lethality by transgene-complementation
Tebbs, R. S., Thompson, L. H., & Cleaver, J. E. (2003) · DNA repair · doi:10.1016/j.dnarep.2003.08.007 · Cited by 63
Foijer, F., Albacker, L. A., Bakker, B., Spierings, D. C. J., Yue, Y., Xie, S. Z.-J., Davis, S. H., Lutum-Jehle, A., Takemoto, D., Hare, B. J., et al. (2017) · eLife · doi:10.7554/elife.20873 · Cited by 65
Self-citationKnockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
Blackburn, A. C., & Jerry, D. J. (2002) · Breast Cancer Research · doi:10.1186/bcr427 · Cited by 67
French, J. E., Lacks, G. D., Trempus, C., Dunnick, J. K., Foley, J., Mahler, J., Tice, R. R., & Tennant, R. W. (2001) · Carcinogenesis · doi:10.1093/carcin/22.1.99 · Cited by 65
Electroporation of Murine Embryonic Stem Cells: A Step‐by‐Step Guide
Tompers, D. M., & Labosky, P. A. (2004) · STEM CELLS · doi:10.1634/stemcells.22-3-243 · Cited by 57
p53 as an intervention target for cancer and aging
Hasty, P., & Christy, B. A. (2013) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v3i0.22702 · Cited by 56
Mahler, J. F., Flagler, N. D., Malarkey, D. E., Mann, P. C., Haseman, J. K., & Eastin, W. C. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600406 · Cited by 55
Perkins, S. N. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.989 · Cited by 55
Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells
Klauzińska, M., Baljinnyam, B., Raafat, A. M., Rodriguez‐Canales, J., Strizzi, L., Greer, Y. E., Rubin, J. S., & Callahan, R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22924 · Cited by 61
Susceptibility of p53-deficient mice to induction of mesothelioma by crocidolite asbestos fibers.
Marsella, J. M., Liu, B. L., Vaslet, C. A., & Kane, A. B. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51069 · Cited by 52
Youngren, K. K. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.4.389 · Cited by 52
Lam, M.-Y., Heaney, J. D., Youngren, K. K., Kawasoe, J. H., & Nadeau, J. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm175 · Cited by 55
Exploiting the rodent model for studies on the pharmacology of lifespan extension
Nadon, N. L. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00185.x · Cited by 48
Yue, H., Diehl, G. E., & Winoto, A. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401523 · Cited by 53
Al-Mulla, F., Keith, W. N., Pickford, I. R., Going, J. J., & Birnie, G. D. (1999) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199904)24:4<306::aid-gcc3>3.0.co;2-5 · Cited by 133
Sakamoto, K., Schmidt, J. W., & Wagner, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_3 · Cited by 49
Mammary tumor modifiers in BALB/cJ mice heterozygous for p53
Koch, J. G., Gu, X., Han, Y., El‐Naggar, A. K., Olson, M. V., Medina, D., Jerry, D. J., Blackburn, A. C., Peltz, G., Amos, C. I., et al. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9028-2 · Cited by 53
Blackburn, A. C., McLary, S. C., Naeem, R. C., Luszcz, J., Stockton, D. W., Donehower, L. A., Mohammed, M., Mailhes, J. B., Soferr, T., Naber, S. P., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3435 · Cited by 54
Self-citationSpindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice
Chi, Y., Ward, J. M., Cheng, L., Yasunaga, J., & Jeang, K. (2008) · International Journal of Cancer · doi:10.1002/ijc.24094 · Cited by 49
DisruptingTP53 in mouse models of human cancers
Parant, J. M., & Lozano, G. (2003) · Human Mutation · doi:10.1002/humu.10186 · Cited by 44
Bouwman, P., Drost, R., Klijn, C., Pieterse, M., Gulden, H. V. D., Song, J., Szuhai, K., & Jonkers, J. (2011) · The Journal of Pathology · doi:10.1002/path.2861 · Cited by 43
Antoch, M. P., Toshkov, I. A., Kuropatwinski, K. K., & Jackson, M. (2013) · Cell Cycle · doi:10.4161/cc.26614 · Cited by 42
Blagosklonny, M. V. (2012) · Aging · doi:10.18632/aging.100475 · Cited by 41
Genetically altered mice: phenotypes, no phenotypes, and Faux phenotypes
Barthold, S. W. (2004) · Genetica · doi:10.1007/s10709-004-1439-3 · Cited by 45
Anisimov, V. N. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00262-7 · Cited by 41
Effects of flanking genes on the phenotypes of mice deficient in basigin/CD147
Chen, S., Kadomatsu, K., Kondo, M., Toyama, Y., Toshimori, K., Ueno, S., Miyake, Y., & Muramatsu, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.232 · Cited by 43
Ariffin, H., Hainaut, P., Puzio-Kuter, A., Choong, S. S., Chan, A. S. L., Tolkunov, D., Rajagopal, G., Kang, W., Lim, L. L. W., Krishnan, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417322111 · Cited by 39
Preclinical Models of Malignant Mesothelioma
Testa, J. R., & Berns, A. J. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00101 · Cited by 40
Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis
Itoh, T., Iwashita, S., Cohen, M. B., Meyerholz, D. K., & Linn, S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm107 · Cited by 60
UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53
Jiang, W., Ananthaswamy, H. N., Muller, H. K., Ouhtit, A., Bolshakov, S. V., Ullrich, S. E., El‐Naggar, A. K., & Kripke, M. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171066498 · Cited by 41
Gostissa, M., Bianco, J. M., Malkin, D. J., Kutok, J. L., Rodig, S. J., Morse, H. C., Bassing, C. H., & Alt, F. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222570110 · Cited by 34
Genetically engineered mouse models of astrocytoma: GEMs in the rough?
Reilly, K. M., & Jacks, T. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0375 · Cited by 36
Sensitized polygenic trait analysis
Matin, A., & Nadeau, J. H. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02528-8 · Cited by 34
Transgenic and gene knockout mice in gastric cancer research
Jiang, Y., & Yu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12467 · Cited by 37
Perkins, S. N., Hursting, S. D., Phang, J. M., & Haines, D. C. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00270.x · Cited by 32
Metadata
- Authors
- Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A., Park, S. H., Thompson, T., Ford, R. J., & Bradley, A.
- Affiliations
- Baylor College of Medicine (US)
- Harvard University (US)
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Donehower, Lawrence A.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 1995-09
- Volume
- 14
- Issue
- 1
- Pages
- 16-22
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2093294267
- Cited by
- 252
- References
- 20
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 11 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 7 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 12
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Carcinogenesis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-50588, CA-16672, R01CA050588, CA54897, R01CA054897, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Keywords
- p53 deficiency, carcinogenesis, genetic background, 129/Sv mice, malignant teratoma, thymic lymphoma, B-cell lymphoma, Li-Fraumeni syndrome, cancer susceptibility, spontaneous tumors
- MeSH terms
- Alleles, Animals, Crosses, Genetic, Disease Models, Animal, Genetic Engineering, Heterozygote, Humans, Lymphoma, Mice, Inbred C57BL, Mice, Mutant Strains, Neoplasms, Experimental, Genes, p53, Tumor Suppressor Protein p53, Li-Fraumeni Syndrome, Genetic Predisposition to Disease, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.